Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 356.86 Million | USD 669.88 Million | 6.50% | 2024 |
The global voice prosthesis devices market size was worth around USD 356.86 million in 2024 and is predicted to grow to around USD 669.88 million by 2034, with a compound annual growth rate (CAGR) of roughly 6.50% between 2025 and 2034.
Voice prostheses are medical devices used for patients who have undergone total laryngectomy. The surgery is a medical procedure involving the removal of the larynx, also known as the voice box, due to laryngeal cancer or extreme damage to the larynx. Voice prosthesis is placed into a tracheoesophageal puncture (TEP) either during or after surgery. The valve allows patients to produce sounds by expelling air from the lungs through the valve into the mouth. The process of placing a voice prosthesis into TEP is also referred to as surgical voice restoration. Once the patients are comfortable with using a voice prosthesis, they may opt for other types of hands-free valves. During the forecast period, demand for voice prostheses is projected to continue growing due to the growing number of larynx-related cancer cases across the globe.
Additionally, the growing expansion of the healthcare sector and rising demand for quality medical care will facilitate improved revenue in the industry. However, a major drawback may result from the high cost of surgical intervention associated with laryngectomy, as well as the limited access to these devices in struggling economies. Furthermore, limited awareness and insufficient skilled professionals may also impact market revenue in the long run. The industry is expected to benefit from the rising advancements in voice prosthesis technology.
Growth Drivers
Will the growing prevalence of laryngeal cancer fuel the voice prosthesis devices market expansion rate?
The global voice prosthesis devices market is expected to be driven by the rising prevalence of laryngeal cancer across the globe. Symptoms of voice box cancer include persistent sore throat, hoarseness, and voice changes. One of the most common treatments for laryngeal cancer is surgical intervention, which deals with the removal of part of or all of the larynx. Voice box cancer is caused by multiple factors. For instance, according to the Cleveland Clinic, human papillomavirus (HPV), which is a sexually transmitted infection (STI), can cause laryngeal cancer. Excessive consumption of alcohol and tobacco can also lead to cancer of the voice box.
Additionally, men are around 5 times more susceptible to laryngeal cancer than women. Around 1 in every 4 people who have neck or head cancer are also vulnerable to voice box cancer. Medical experts recommend undergoing complete removal of the larynx in case of advanced cases of laryngeal cancer. Since patients who have undergone total removal of the larynx are unable to speak as they did before, voice prosthesis devices allow them to create vibrations that can be converted into speech using TEP. It is a surgical opening between the esophagus and trachea.
Rising access to advanced healthcare will propel industry revenue during the forecast period
State healthcare investments have increased over the years across the globe. In addition to this, private companies operating in the medical care sector have also made novel investments and launched projects to promote access to quality healthcare for the global population. For instance, in September 2022, Apollo Hospitals Group and the Eclipse Group in Africa signed a Memorandum of Understanding (MoU). The agencies have signed an agreement to develop a cancer treatment center in Tanzania.
Apollo Hospitals will provide advanced cancer care treatments in accordance with the MoU. In February 2025, the Indian government announced several key undertakings on its official website, indicating that the Union Budget of 2025-2026 will prioritize them. It includes focusing on cancer care. The global voice prosthesis devices market will benefit as healthcare expenditure continues to grow worldwide.
Restraints
High cost of devices and medical procedures will affect market revenue in the long run
The global voice prosthesis devices industry is projected to be affected by the high cost of the devices. For instance, the average cost of a standard voice prosthesis can range between USD 300 and USD 500, with premium models being more expensive. On the other hand, the high expenses associated with the surgical procedure required for implantation of the voice prosthesis further add to the overall cost of treatment. Lack of sufficient reimbursement policies may discourage higher revenue in the industry during the forecast period.
Opportunities
Growing launch of new products in the market generates growth opportunities
The global voice prosthesis devices market is expected to generate growth opportunities due to the rising launch of new products in the market. In March 2024, bioengineers at the University of California, Los Angeles (UCLA) launched a new flexible, thin device that sticks to the neck. The device then translates the muscle movements of the larynx into speech. The adhesive patch is developed using Machine Learning (ML) and Artificial Intelligence (AI). Furthermore, it is a self-powered technology helping people with speech difficulties caused by problems in the vocal cords.
In January 2024, the All India Institute of Medical Sciences (AIIMS) and the Indian Institute of Technology (IIT), Delhi, launched a low-cost voice prosthesis. In addition, AIIMS will offer the new device free of cost to patients undergoing treatment at the institute. In October 2021, InHealth Technologies, a leading provider of ear, nose, and throat (ENT) products, commercially launched the Blom-Singer SpeakFree HME Hands-Free Valve. The device is developed for people who have undergone a total laryngectomy.
According to official reports, SpeakFree™ HME Hands Free does not require manual closure for speaking, and it is the first single-use heat and moisture exchange (HME) cartridge equipped with a flexible, adjustable valve. Rising technological advancements in voice prosthesis devices will be helpful for the future of the industry players.
Challenges
Does the lack of skilled professionals and effective infrastructure challenge the voice prosthesis devices market growth trends?
The global voice prosthesis devices industry is projected to be challenged by the lack of skilled professionals with expertise in the surgical procedure required for placing a voice prosthesis.
Additionally, the limited healthcare infrastructure supporting large-scale surgical interventions concerning the use of voice prostheses may further impact market revenue. The industry will also be affected by strict regulatory approvals required for commercial sale and application of new-generation voice prosthesis equipment.
Report Attributes | Report Details |
---|---|
Report Name | Voice Prosthesis Devices Market |
Market Size in 2024 | USD 356.86 Million |
Market Forecast in 2034 | USD 669.88 Million |
Growth Rate | CAGR of 6.5% |
Number of Pages | 212 |
Key Companies Covered | Coloplast A/S (Atos Medical AB), Atos Medical AB, HEIMOMED Heinze GmbH & Co. KG, Servona GmbH, Prolaryn Therapeutics, Andreas Fahl Medizintechnik‑Vertrieb GmbH, Humantechnik GmbH, Teleflex Incorporated (Smiths Medical, ICU Medical), Freudenberg Medical, InHealth Technologies, RSLSteiner GmbH, ICU Medical Inc., Hood Laboratories Inc., Orbisana Healthcare GmbH, Blom‑Singer (CR Bard)., and others. |
Segments Covered | By Product, By Valve Type, By End-User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2019 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global voice prosthesis devices market is segmented based on product, valve type, end-user, and region.
Based on the product, the global market segments are non-dwelling voice prosthesis and indwelling voice prosthesis. In 2024, the highest revenue was listed in the indwelling voice prosthesis segment, accounting for nearly 65% of the final results. According to industry analysis, indwelling products have longer functional lives and are generally recommended by clinicians. Furthermore, they are easily available at healthcare facilities and ENT centers. However, they are the most expensive compared to non-dwelling counterparts.
Based on valve type, the global voice prosthesis devices industry is divided into Groningen valve, Blom-Singer valve, and Provox valve.
Based on the end-user, the global industry is fragmented into ambulatory surgical services and hospitals. In 2024, more than 90% of the revenue was listed in the hospitals segment. The high number of patient footfalls at healthcare facilities is a major segmental growth driver. The increase in the number of hospitals worldwide has further improved access to quality care. A large number of government-run hospitals are offering voice prostheses at a reasonable price for their patients, resulting in amplified market revenue.
What factors will help North America dominate the voice prosthesis devices market during the forecast period?
The global voice prosthesis devices market is expected to be led by North America during the forecast period. In 2024, it was the highest revenue-generating region among other economies. North America is home to a robust and thriving healthcare infrastructure. It boosts specialized training centers, skilled professionals, and the availability of cutting-edge diagnostic and treatment tools. Furthermore, the high disposable income of the general population, along with favorable reimbursement policies, helps the region dominate.
The Asia-Pacific region is a rapidly growing market with exceptional growth opportunities. The region is experiencing an increase in demand for healthcare as the general population's rate of illness continues to rise. In addition to this, regional governments are increasing state-backed initiatives to develop more comprehensive national healthcare programs offering low-cost, yet high-quality treatments to patients from low-income families.
Furthermore, technological advancements in cancer care across the Asia-Pacific will promote improved revenue in the region during the forecast period. In March 2022, researchers at the University of Tokyo unveiled an artificial larynx prototype designed for individuals who have lost their voice. They have developed Syrinx, an ML-based wearable, hands-free electrolarynx.
The global voice prosthesis devices market is led by players like:
By Product
By Valve Type
By End-User
By Region
FrequentlyAsked Questions
Voice prostheses are medical devices used for patients who have undergone total laryngectomy.
The global voice prosthesis devices market is expected to be driven by the rising prevalence of laryngeal cancer across the globe.
According to study, the global voice prosthesis devices market size was worth around USD 356.86 million in 2024 and is predicted to grow to around USD 669.88 million by 2034.
The CAGR value of the voice prosthesis devices market is expected to be around 6.50% during 2025-2034.
The global voice prosthesis devices market is expected to be led by North America during the forecast period.
The global voice prosthesis devices market is led by players like Coloplast A/S (Atos Medical AB), Atos Medical AB, HEIMOMED Heinze GmbH & Co. KG, Servona GmbH, Prolaryn Therapeutics, Andreas Fahl Medizintechnik‑Vertrieb GmbH, Humantechnik GmbH, Teleflex Incorporated (Smiths Medical, ICU Medical), Freudenberg Medical, InHealth Technologies, RSLSteiner GmbH, ICU Medical Inc., Hood Laboratories, Inc., Orbisana Healthcare GmbH, and Blom‑Singer (CR Bard).
The report explores crucial aspects of the voice prosthesis devices market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed